BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 18, 2005
View Archived Issues
Data on the survival effects of seocalcitol in advanced HCC
Read More
Remofovir reported to reduce viral load of patients with chronic hepatitis B
Read More
LB-80380 shows promise in the treatment of lamivudine-resistant hepatitis B
Read More
Idenix presents new data on drugs for chronic hepatitis
Read More
Good analgesic efficacy found with lamotrigine plus sertraline in neuropathic pain
Read More
Bioaccelerate Holdings and Symbollon enter agreement for IoGen
Read More
Cloretazine studied in phase I trial for pediatric brain tumors
Read More
SPI-153 enters phase II trial for BPH
Read More
Response submitted to FDA for Glumetza NDA
Read More
Priority review for SomatoKine
Read More
Orchid BioSciences seeks approval to change name to Orchid Cellmark
Read More
YM BioSciences to acquire Delex Therapeutics
Read More
Lilly licenses therapeutic proteins from Xencor
Read More
SCOLR Pharma adds three drug targets to CDT drug development program
Read More
Evotec OAI extends discovery chemistry agreement with Roche
Read More
Novel analgesic drugs presented in recent patent literature
Read More
Chemokine CCR5 modulators and their use as anti-HIV agents claimed by ViroChem and AstraZeneca
Read More
Acusphere amends phase III plans for AI-700
Read More
SDF-1 antagonist significantly reduces osteosarcoma metastases in animal model
Read More
Intranasal Technology inlicenses Aegis' Intravail drug delivery technology
Read More
ZSTK-474: a novel PI3K inhibitor with a promising preclinical profile
Read More
New indication approved for Hyzaar
Read More
Kos and Barr sign agreements to settle Niaspan patent litigation
Read More
Avastin improves progression-free survival in phase III breast cancer study
Read More
Albuferon safe and active in phase II trial in hepatitis C patients
Read More